Home NDC 64764-105 Eohilia
Product NDC 64764-105
11-digit product format 647640105
Labeler code 64764
Product ID 64764-105_6b8f012a-d7af-4200-a5b8-5a56f6962ccd
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Budesonide
Dosage form SUSPENSION
Route ORAL
Labeler TAKEDA PHARMACEUTICALS AMERICA, INC.
Application NDA213976
Marketing category NDA
Marketing start 2024-02-09
Substance BUDESONIDE
Active strength 2 mg/10mL
Pharmacologic classes Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213976-001 EOHILIA BUDESONIDE 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N213976-001 11197822 2026-11-09 Drug product 2024-03-04 N213976-001 11413296 2026-11-09 Drug product 2024-03-04 N213976-001 8497258 2026-11-09 U-3820 2024-03-04 N213976-001 8679545 2026-11-09 Drug product 2024-03-04 N213976-001 8975243 2026-11-09 U-3820 2024-03-04 N213976-001 9119863 2026-11-09 U-3820 2024-03-04 N213976-001 11357859 2028-11-12 U-3820 2024-03-04 N213976-001 10293052 2028-11-22 Drug product 2024-03-04 N213976-001 9050368 2029-08-01 Drug product 2024-03-04 N213976-001 8324192 2029-08-03 U-3820 2024-03-04 N213976-001 11260064 2039-01-10 Drug product 2024-03-04 N213976-001 11564934 2039-01-10 U-3820 2024-03-04
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N213976-001 NP 2027-02-09 N213976-001 ODE-466 2031-02-09
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 6a51e52b5d6a…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N213976-001 EOHILIA 2MG/10ML SUSPENSION / ORAL RLD, RS 2024-02-09 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 5 · 192 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N213976-001 11197822 2026-11-09 Drug product 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 11413296 2026-11-09 Drug product 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 8497258 2026-11-09 U-3820 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 8679545 2026-11-09 Drug product 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 8975243 2026-11-09 U-3820 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 9119863 2026-11-09 U-3820 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 11357859 2028-11-12 U-3820 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 10293052 2028-11-22 Drug product 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 9050368 2029-08-01 Drug product 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 8324192 2029-08-03 U-3820 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 11260064 2039-01-10 Drug product 2024-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213976-001 11564934 2039-01-10 U-3820 2024-03-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 11197822 2026-11-09 Drug product 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 11413296 2026-11-09 Drug product 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 8497258 2026-11-09 U-3820 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 8679545 2026-11-09 Drug product 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 8975243 2026-11-09 U-3820 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 9119863 2026-11-09 U-3820 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 11357859 2028-11-12 U-3820 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 10293052 2028-11-22 Drug product 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 9050368 2029-08-01 Drug product 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 8324192 2029-08-03 U-3820 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 11260064 2039-01-10 Drug product 2024-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213976-001 11564934 2039-01-10 U-3820 2024-03-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213976-001 11197822 2026-11-09 Drug product 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 11413296 2026-11-09 Drug product 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 8497258 2026-11-09 U-3820 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 8679545 2026-11-09 Drug product 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 8975243 2026-11-09 U-3820 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 9119863 2026-11-09 U-3820 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 11357859 2028-11-12 U-3820 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 10293052 2028-11-22 Drug product 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 9050368 2029-08-01 Drug product 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 8324192 2029-08-03 U-3820 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 11260064 2039-01-10 Drug product 2024-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213976-001 11564934 2039-01-10 U-3820 2024-03-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213976-001 11197822 2026-11-09 Drug product 2024-03-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213976-001 11413296 2026-11-09 Drug product 2024-03-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213976-001 8497258 2026-11-09 U-3820 2024-03-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213976-001 8679545 2026-11-09 Drug product 2024-03-04 fd3edfee7708…
Observed Orange Book exclusivity history# Additional Listing Data#
Finished product Yes
Brand name base Eohilia
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BUDESONIDE 2 mg/10mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination Q3OKS62Q6X Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2675280 Internal RxNorm lookup 2675286 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 64764-105-00 Eohilia 10 in 1 CARTON SUSPENSION 10 6 64764-105-01 Eohilia 10 mL in 1 POUCH SUSPENSION 10 6 64764-105-10 Eohilia 10 mL in 1 POUCH SUSPENSION 10 6 64764-105-60 Eohilia 60 in 1 CARTON SUSPENSION 60 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 64764-105 EOHILIA (BUDESONIDE) SUSPENSION [TAKEDA PHARMACEUTICALS AMERICA, INC.] 6 Current NDC, 4 package rows 20250206_56f2023a-69b2-4470-b4ad-af7ec1be527a.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Eohilia BUDESONIDE TAKEDA PHARMACEUTICALS AMERICA, INC. 56f2023a-69b2-4470-b4ad-af7ec1be527a 2025-02-03 Warnings, Adverse reactions Exact identifier application applno (NDA): 213976 application number: NDA213976 ndc (product): 64764-105
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 64764-105-00 64764010500 10 POUCH in 1 CARTON (64764-105-00) / 10 mL in 1 POUCH (64764-105-01) 10 pouch 2024-02-09 No No Current 64764-105-01 64764010501 10 mL in 1 POUCH 10 ml Historical 64764-105-10 64764010510 10 mL in 1 POUCH 10 ml Historical 64764-105-60 64764010560 60 POUCH in 1 CARTON (64764-105-60) / 10 mL in 1 POUCH (64764-105-10) 60 pouch 2024-02-09 No No Current